We’re hiring – COO

COMPANY DESCRIPTION Exogenus Therapeutics is an innovative biotech start-up dedicated to early stage development of therapeutic tools. Using an exosome-based platform technology, Exogenus is developing biologic products for diseases with high unmet needs, such as inflammatory and autoimmune diseases. Driven by the urgency imposed by the COVID-19 pandemic, the company is currently developing solutions for Read more about We’re hiring – COO[…]

We’re hiring – Researcher

 COMPANY DESCRIPTION  Exogenus Therapeutics is an innovative biotech start-up dedicated to early stage development of therapeutic tools. Using an exosome-based platform technology, Exogenus is developing biologic products for diseases with high unmet needs, such as inflammatory and autoimmune diseases. Driven by the urgency imposed by the COVID-19 pandemic, the company is currently developing solutions for Read more about We’re hiring – Researcher[…]

We’re hiring – R&D and Innovation Associate | Inflammatory and Autoimmune Diseases

Join a young, dynamic and high achieving team! Located in Biocant Park, a leading Biotechnology industrial park in central Portugal, Exogenus Therapeutics is a startup developing early stage exosome-based therapies. We are hiring an R&D and Innovation Associate to lead the development of a new product pipeline for the treatment of Inflammatory and Autoimmune Diseases Read more about We’re hiring – R&D and Innovation Associate | Inflammatory and Autoimmune Diseases[…]

Exogenus’ Scientic Officer speaker at World Advanced Therapies and Regenerative Medicine Congress 2019

Joana Correia, founder, Executive Director and Chief Scientific Officer of Exogenus Therapeutics will be presenting at the 14th World Advanced Therapies and Regenerative Medicine Congress taking place 15th to 17th of May in London. Joana will be presenting Exogenus’s experience on the specific case of umbilical cord blood derived exosomes and its therapeutic potential at Read more about Exogenus’ Scientic Officer speaker at World Advanced Therapies and Regenerative Medicine Congress 2019[…]

Exogenus Therapeutics wins Prémio Empreendedor XXI 2018

Exogenus Therapeutics is the winner of the 2nd edition of Prémio Empreendedor XXI, Portugal – North and Central Regions. This prize is organized by BPI and DayOne, a division of CaixaBank specialized in technological companies, in partnership with Agência Nacional de Inovação and the Alto Patrocínio do Ministério da Economia. Exogenus Therapeutics was selected among Read more about Exogenus Therapeutics wins Prémio Empreendedor XXI 2018[…]

Exogenus Therapeutics on the Top 500 deeptech startups shortlist of Hello Tommorrow

Exogenus is amongst the 500 deeptech startups running for the Hello Tomorrow Global Challenge. The Hello Tomorrow Global Challenge is a worldwide renowned science & technology startup competition designed specifically to address the needs of deeptech entrepreneurs across several different industries and technologies. Finalists will be announced in January 2019 and the Global Summit will take place in Read more about Exogenus Therapeutics on the Top 500 deeptech startups shortlist of Hello Tommorrow[…]

Estamos a recrutar um Estagiário(a) Adminstrativo(a)

  Exogenus Therapeutics é uma start-up de base tecnológica dedicada ao desenvolvimento de terapias inovadoras. Com uma equipa jovem e dinâmica localizada no parque biotecnológico de Cantanhede (Biocant Park), pretende recrutar um estagiário para estágio IEFP para apoiar a atividade administrativa e financeira fazendo a ponte entre a Direção e os serviços de Contabilidade, com Read more about Estamos a recrutar um Estagiário(a) Adminstrativo(a)[…]

Graça Raposo joins Exogenus Therapeutics Advisory Board

We are glad to announce that Graça Raposo, one of the first scientists worldwide who recognized the biological role of Extracellular Vesicles (EVs) in human biology, has joined our Advisory Board. Commonly referred within experts as “the mother of exosomes”, Graça Raposo has been extensively recognized in the field, and received many distinctions such as the CNRS Read more about Graça Raposo joins Exogenus Therapeutics Advisory Board[…]

Exogenus presents poster at ISEV 2018 Annual meeting

Exogenus is presenting a poster at ISEV 2018 Annual meeting taking place in Barcelona between 2-6 May. With over 1,000 attendees, ISEV2018 gathers experts and researchers on extracellular vesicle research, covering the latest progresses in exosomes, microvesicles. Exogenus is one of the few companies worldwide developing EV-based therapeutics. Silvia Rodrigues is presenting a poster on “Development Read more about Exogenus presents poster at ISEV 2018 Annual meeting[…]

Technology licensed by Exogenus presented at 14th Portuguese Congress of Diabetes

Exogenus is developing promising therapeutics for the treatment of chronic and acute wounds, among which are diabetic foot ulcers, some of the most debilitating and hard-to-heal. The lead technology licensed and under development by Exogenus for the treatment of wounds, is owned by Crioestaminal and Biocant, and relates to the use of exosomes secreted by Read more about Technology licensed by Exogenus presented at 14th Portuguese Congress of Diabetes[…]